{
    "SPADE_UN_11601": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_11601",
            "Peptide Name": "K1K8",
            "Source": "Synthetic construct",
            "Family": "Belongs to the Hp1404 family",
            "Gene": "Not found",
            "Sequence": "KILGKLWKGVKSIF",
            "Sequence Length": 14,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "[Ref.26952110] Gram-positive bacteria:Staphylococcus aureus AB94004 (MIC=6.25μg/mL), Staphylococcus aureus ATCC6538 (MIC=12.5μg/mL), Staphylococcus aureus ATCC25923 (MIC=12.5μg/mL), Staphylococcus aureus MRSA P1381 (MIC=6.25μg/mL), Staphylococcus aureus MRSA P1374 (MIC=6.25μg/mL);Gram-negative bacteria:Escherichia coli AB94012 (MIC=25μg/mL), Escherichia coli ATCC25922 (MIC=50μg/mL), Pseudomonas aeruginosa AB93066 (MIC=50μg/mL), Pseudomonas aeruginosa ATCC9027 (MIC=50μg/mL)",
            "Hemolytic Activity": "[Ref.26952110] 10% hemolysis at 400μg/mL against human red blood cells",
            "Cytotoxicity": "[Ref.26952110] The cell vaibility of HFF cell lines is 100%, 108%, 105%  and 38% at peptide concentrations of 0 μg/ml, 50 μg/ml, 100 μg/ml and 200 μg/ml.The cell viability of HEK293T cell lines is 105%, 125%, 101% and 21% at peptide concentrations of",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C80H133N19O16",
            "Mass": 1617.03,
            "PI": 10.48,
            "Net Charge": 4,
            "Hydrophobicity": 0.39,
            "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min",
            "Function": "Antibacterial activity against the Gram-negative and Gram-positive bacteria",
            "Literature": [
                {
                    "Title": "K1K8 an Hp1404-derived antibacterial peptide",
                    "Pubmed ID": "26952110",
                    "Reference": "Appl Microbiol Biotechnol. 2016 Jun;100(11)5069-77.",
                    "Author": "Li Z, Liu G, Meng L, Yu W, Xu X, Li W, Wu Y, Cao Z.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=26952110"
                },
                {
                    "Title": "Mechanism of action of a novel recombinant peptide, MP1102, against Clostridium perfringens type C",
                    "Pubmed ID": "",
                    "Author": "Zong L, Teng D, Wang X, Mao R, Yang n, Hao Y, Wang J"
                }
            ],
            "Frequent Amino Acids": "KGI",
            "Absent Amino Acids": "ACDEHMNOPQRTUY",
            "Basic Residues": 4,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 7,
            "Polar Residues": 6,
            "Positive Residues": 4,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_03354",
                    "Similarity": 1.0,
                    "Sequence": "AIGNILKTLGNLAQKILGK"
                },
                {
                    "SPADE_ID": "SPADE_N_05584",
                    "Similarity": 1.0,
                    "Sequence": "MGALIKTGAKIIGSGAAGGLGTYIGHKILGK"
                },
                {
                    "SPADE_ID": "SPADE_N_09241",
                    "Similarity": 1.0,
                    "Sequence": "VNWKKILG"
                }
            ]
        }
    }
}